Information on adverse event reporting can be found at the bottom of the page.
Pfizer has a long-standing commitment to guiding women on a broad range of health issues. Affecting 51% of the UK population1, Women’s Health is a topic that Pfizer is committed to helping healthcare professionals provide the support required, to inform and empower patients across the generations. This page provides healthcare professionals access to a range of product related information and downloadable material to help patients feel confident about their treatment.
Should you have any questions relating to our work in Women's Health, please do contact the team.
Access clinical information and educational resources.
Sayana-Press prescribing information
Access clinical information and support resources.
Depo-Provera prescribing information
Connect with the Pfizer UK Women's Health team.
1. Office of National Statistics. Overview of the UK population: January 2021
https://www.ons.gov.uk/peoplepopulationandcommunity/populationandmigration/populationestimates/articles/overviewoftheukpopulation/january2021 (accessed November 2021)
These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.
I confirm that I am a healthcare professional* resident in the United Kingdom.
If you select 'No', you will be redirected to Pfizer.co.uk where you will be able to access reference information on Pfizer's prescription medicines.
*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.
PP-PFE-GBR-3863. November 2021